Passive Transfer of Animal-Derived Polyclonal Hyperimmune Antibodies Provides Protection of Mice from Lethal Lassa Virus Infection
Background: Lassa virus (LASV) can cause severe acute systemic infection in humans. No approved antiviral drugs or vaccines are currently available. Antibody-based therapeutics are considered a promising treatment strategy in the management of LASV disease. Methods: We used chimeric Ifnar?/? C57B...
Furkejuvvon:
Váldodahkkit: | , , , |
---|---|
Materiálatiipa: | Artihkal |
Giella: | eaŋgalasgiella |
Almmustuhtton: |
Philipps-Universität Marburg
2023
|
Fáttát: | |
Liŋkkat: | PDF-ollesdeaksta |
Fáddágilkorat: |
Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
|
No abstracts were found for this record.